A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer

European Journal of Cancer Care

Volumn 18, Issue 6, 2009, Pages 545-555

  McDowell, M E ^a   Occhipinti, Stefano ^a   Gardiner, R A ^b   Baade, P D ^c,d   Steginga, S K ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Family history; Prostate cancer; Review; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANXIETY; ATTITUDE TO HEALTH; BLOOD; HEALTH BEHAVIOR; HUMAN; MALE; MASS SCREENING; PEDIGREE; PERCEPTION; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; STATISTICS;

ANXIETY; ATTITUDE TO HEALTH; HEALTH BEHAVIOR; HUMANS; MALE; MASS SCREENING; PEDIGREE; PERCEPTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 70350495401     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2008.01046.x     Document Type: Review

References (62)

1. Andriole G.L., Levin D.L., Crawford E.D., Gelmann E.P., Pinsky P.F., Chia D., Kramer B.S., Reding D., Church T.R., Grubb R.L., Izmirlian G., Ragard L.R., Clapp J.D., Prorok P.C. Gohagan J.K. (2005) Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screening round of a randomized trial. Journal of The National Cancer Institute 97, 433 438. (Pubitemid 40528606)
2. Arar N., Thompson I., Sarosdy M., Harris M., Shepherd D., Troyer D. Plaetke R. (2000) Risk perceptions among patients and their relatives regarding prostate cancer and its heredity. Prostate Cancer and Prostatic Diseases 3, 176 185.
3. Baade P.D., Coory M.D. Aitken J.F. (2004) International trends in prostate-cancer mortality: the decrease is continuing and spreading. Cancer Causes and Control 15, 237 241.
4. Beebe-Dimmer J.L., Wood D.P., Gruber S.B., Chilson D.M., Zuhlke K.A., Claeys G.B. Cooney K.A. (2004) Risk perception and concern among brothers of men with prostate carcinoma. Cancer 100, 1537 1544.
5. Bermejo J.L. Hemminki K. (2005) Familial risk of cancer shortly after diagnosis of the first familial tumor. Journal of the National Cancer Institute 97, 1575 1579.
6. Bloom J.R., Stewart S.L., Oakley-Girvans I., Banks P.J. Chang S. (2006) Family history, perceived risk, and prostate cancer screening among African-American men. Cancer Epidemiology, Biomarkers and Prevention 15, 2167 2173.
7. Bock C.H., Peyser P.A., Gruber S.B., Bonnell S.E., Tedesco K.L. Cooney K.A. (2003) Prostate cancer early detection practices among men with a family history of disease. Urology 62, 470 475.
8. Bratt O., Kristoffersson U., Lundgren R. Olsson H. (1997) Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 50, 360 365.
9. Bratt O., Damber J.E., Emanuelsson M., Kristoffersson U., Lundgren R., Olsson H. Gronberg H. (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. European Journal of Cancer 36, 235 241.
10. Bratt O., Emanuelsson M. Gronberg H. (2003) Psychological aspects of screening in families with hereditary prostate cancer. Scandinavian Journal of Urology and Nephrology 37, 5 9.
11. Bruner D.W., Moore D., Parlanti A., Dorgan J. Engstrom P. (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. International Journal of Cancer 107, 797 803.
12. Catalona W.J., Antenor J.A.V. Roehl K.A. (2002) Screening for prostate cancer in high risk populations. Journal of Urology 168, 1980 1984.
13. Cormier L., Guillemin F., Valeri A., Fournier G., Cussenot O., Mangin P. Litwin M.S. (2002a) Impact of prostate cancer screening on health-related quality of life in at-risk families. Urology 59, 901 906.
14. Cormier L., Kwan L., Reid K. Litwin M.S. (2002b) Knowledge and beliefs among brothers and sons of men with prostate cancer. Urology 59, 895 900.
15. Cormier L., Valéri A., Azzouzi R., Fournier G., Cussenot O., Berthon P., Guillemin F. Mangin P. (2002c) Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. The Prostate 51, 276 285.
16. Cormier L., Reid K., Kwan L. Litwin M.S. (2003) Screening behavior in brothers and sons of men with prostate cancer. Journal of Urology 169, 1715 1719.
17. Eibner F., Barth R., Helmes A. Bengel J. (2006) Variations in subjective breast cancer risk estimations when using different measurements for assessing breast cancer risk perception. Health Risk and Society 8, 197 210.
18. Gallina A., Karakiewicz P.I., Chun F.K.H., Briganti A., Graefen M., Montorsi F., Walz J., Jeldres C., Erbersdobler A., Salonia A., Suardi N., Deho F., Schlomm T., Scattoni V., Haese A., Heinzer H., Valiquette L., Rigatti P. Huland H. (2007) Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer. BJU International 99, 1404 1408.
19. Gambert S.R. (2001) Screening for prostate cancer. International Urology and Nephrology 33, 249 257.
20. Gronberg H. (2003) Prostate cancer epidemiology. The Lancet 361, 859 864.
21. Hall S.E., Holman C.D.A.J., Wisniewski Z.S. Semmens J. (2005) Prostate cancer: socioeconomic, geographical and private-health insurance effects on care and survival. BJU International 95, 51 58.
22. Harris R. Lohr K.N. (2002) Screening for prostate cancer: an update of the evidence for the U.S. preventive services task force. Annals of Internal Medicine 137, 917 929. (Pubitemid 35416628)
23. Hemminki K., Rawal R. Bermejo J.L. (2005) Prostate cancer screening, changing age-specific incidence trends and implications on familial risk. International Journal of Cancer 113, 312 315.
24. Hsing A.W. Devesa S.S. (2001) Trends and patterns of prostate cancer: what do they suggest? Epidemiologic Reviews 23, 3 13.
25. Ilic D., O'Connor D., Green S. Wilt T. (2006) Screening for prostate cancer. Cochrane Database of Systematic Reviews, 3, 1-25, CD004720.
26. Jacobsen P.B., Lamonde L.A., Honour M., Kash K., Hudson P.B. Pow-Sang J. (2004) Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psycho-Oncology 13, 80 85.
27. Johns L.E. Houlston R.S. (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU International 91, 789 794.
28. Joung I.M.A., Stronks K., Vandemheen H. Mackenbach J.P. (1995) Health behaviors explain part of the differences in self-reported health associated with partner marital-status in the Netherlands. Journal of Epidemiology and Community Health 49, 482 488.
29. Joutsenniemi K.E., Martelin T.P., Koskinen S.V., Martikainen P.T., Harkanen T.T., Luoto R.M. Aromaa A.J. (2006) Official marital status, cohabiting, and self-rated health-time trends in Finland, 1978-2001. European Journal of Public Health 16, 476 483.
30. Kiemeney L.A., Broeders M.J., Pelger M., Kil P.J., Schröder F.H., Witjes J.A. Vasen H.F. (2008) Screening for prostate cancer in Dutch hereditary prostate cancer families. International Journal of Cancer 122, 871 876.
31. Langeberg W.J., Isaacs W.B. Stanford J.L. (2007) Genetic etiology of hereditary prostate cancer. Frontiers in Bioscience 12, 4101 4110.
32. Lichtenstein P., Holm N.V., Verkasalo P.K., Illiadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A. Hemminki K. (2000) Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. New England Journal of Medicine 343, 78 84.
33. Loblaw D.A., Virgo K.S., Nam R., Somerfield M.R., Ben-Josef E., Mendelson D.S., Middleton R., Sharp S.A., Smith T.J., Talcott J., Taplin M., Vogelzang N.J., Wade J.L., III., Bennet C.L. Scher H.I. (2007) Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2007 update of an American society of clinical oncology practice guideline. Journal of Clinical Oncology 25, 1596 1605.
34. Melia J. (2005) Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales. BJU International 95, 4 15.
35. Miller S.M., Diefenbach M.A., Kruus L.K., Watkins-Bruner D., Hanks G.E. Engstrom P.F. (2001) Psychological and screening profiles of first-degree relatives of prostate cancer patients. Journal of Behavioral Medicine 24, 247 258.
36. Myers R.E. (2005) Decision counseling in cancer prevention and control. Health Psychology 24, S71 S77.
37. Neal D.E., Leung H.Y., Powell P.H., Hamdy F.C. Donovan J.L. (2000) Unanswered questions in screening for prostate cancer. European Journal of Cancer 36, 1316 1321.
38. O'Connor A.M., Fiset V., Degrasse C., Graham I.D., Evans W., Stacey D., Laupacis A. Tugwell P. (1999) Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. Journal of the National Cancer Institute, Monographs 67 80.
39. Parkin D.M. (2001) Global cancer statistics in the year 2000. Lancet Oncology 2, 533 543.
40. Parkin D.M., Bray F.I. Devesa S.S. (2001) Cancer burden in the year 2000. The global picture. European Journal of Cancer 37, S4 S66.
41. Peters S.M., Jovell A.J., Garcia-Altes A. Serra-Prat M. (2001) Screening and clinical management of prostate cancer. A cross-national comparison. International Journal of Technology Assessment in Health Care 17, 215 221.
42. Pomerantz M.M., Freedman M.L. Kantoff P.W. (2007) Genetic determinants of prostate cancer risk. BJU International 100, 241 243.
43. Postma R. Schroder F.H. (2005) Screening for prostate cancer. European Journal of Cancer 41, 825 833.
44. Pruthi R.S., Tornehl C., Gaston K., Lee K., Moore D., Carson C.C. Wallen E.M. (2006) Impact of race, age, income, and residence on prostate cancer knowledge, screening behavior, and health maintenance in siblings of patients with prostate cancer. European Urology 50, 64 69.
45. RACGP (Royal Australian College of General Practitioners) (2006) Prostate screening: policy endorsed by the 48th RACGP council, 19 April 2006. Retrieved 30 November, 2006. Available at: http://www.racgp.org.au/Content/NavigationMenu/ Advocacy/RACGPpositionstatements/20060911Prostatescreening.pdf
46. Ross L.E., Uhler R.J. Williams K.N. (2005) Awareness and use of the prostate-specific antigen test among African-American men. Journal of the National Medical Association 97, 963 971.
47. Roumier X., Azzouzi R., Valeri A., Guillemin F., Fournier G., Cussenot O., Mangin P. Cormier L. (2004) Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer. European Urology 45, 280 286.
48. Sanders T., Campbell R., Sharp D. Donovan J. (2003) Risk constructions among people who have a first-degree relative with cancer. Health Risk and Society 5, 53 69.
49. Schaid D.J. (2004) The complex genetic epidemiology of prostate cancer. Human Molecular Genetics 13, R103 121.
50. Schnur J.B., Dilorenzo T.A., Montgomery G.H., Erblich J., Winkel G., Hall S.J. Bovbjerg D.H. (2006) Perceived risk and worry about prostate cancer: a proposed conceptual model. Behavioral Medicine 32, 89 96.
51. Schroder F.H., Denis L.J. Roobol M. (2003) The story of the European randomized study of screening for prostate cancer. BJU International 92, 1 13. (Pubitemid 38091131)
52. Shah M., Zhu K., Palmer R.C. Wu H. (2007) Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men. Preventive Medicine 44, 459 464. (Pubitemid 46691319)
53. Spencer B.A., Babey S.H., Etzioni D.A., Ponce N.A., Brown E.R., Yu H.J., Chawla N. Litwin M.S. (2006) A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma. Cancer 106, 765 774.
54. Staples M.P., Giles G.G., English D.R., Mccredie M.R.E., Severi G., Cui J.S. Hopper J.L. (2003) Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes and Control 14, 161 166.
55. Sweetman J., Watson M., Norman A., Bunstead Z., Hopwood P., Melia J., Moss S., Eeles R., Dearnaley D. Moynihan C. (2006) Feasibility of familial PSA screening: psychosocial issues and screening adherence. British Journal of Cancer 94, 507 512.
56. Talcott J.A., Spain P., Clark J.A., Carpenter W.R., Do Y.K., Hamilton R.J., Galanko J.A., Jackman A. Godley P.A. (2007) Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer 109, 1599 1606.
57. USPSTF (U.S Preventive Services Task Force) (2002) Screening for prostate cancer: recommendations and rationale. Retrieved 30 December, 2007. Available at: http://www.ahrq.gov/clinic/3rduspstf/prostatescr/prostaterr.htm
58. Vadaparampil S.T., Jacobsen P.B., Kash K., Watson I.S., Saloup R. Pow-Sang J. (2004) Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients. Cancer Epidemiology Biomarkers and Prevention 13, 753 758.
59. Weinrich S.P. (2006) Prostate cancer screening in high-risk men: African-American hereditary prostate cancer study network. Cancer 106, 796 803.
60. Wilt T.J. Wilt T.J. (2002) Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer. Seminars in Urologic Oncology 20, 10 7.
61. Zeliadt S.B., Ramsey S.D., Penson D.F., Hall I.J., Ekwueme D.U., Stroud L. Lee J.W. (2006) Why do men choose one treatment over another? Cancer 106, 1865 1874.
62. Zimmerman R.S. Connor C. (1989) Health promotion in context - the effects of significant others on health behavior-change. Health Education Quarterly 16, 57 75.